講者：成佳憲
日期：2016-05-10
觀看: 1320
  • 00:00 1.
    Long-term Treatment Outcomes for Patients with Localized Prostate Cancer in Taiwan NTUH Experience攝護腺癌的放射治療
  • 00:23 2.
    攝護腺癌的治療種類
  • 00:31 3.
    攝護腺癌的放射線治療病人條件
  • 00:48 4.
    攝護腺癌的放射線治療種類
  • 01:23 5.
    Prostate Cancer Radiotherapy at NTUH
  • 01:34 6.
    Radiotherapy Technology at NTUHfor Prostate Cancer
  • 02:31 7.
    Prostate Cancer Radiotherapy at NTUH
  • 02:36 8.
    Radiotherapy Technology at NTUHfor Prostate Cancer
  • 03:15 9.
    Interim Study of Definitive IMRT for Prostate Cancer with 78 Gy at NTUH
  • 03:16 10.
    Radiotherapy Technology at NTUHfor Prostate Cancer
  • 03:17 11.
    Interim Study of Definitive IMRT for Prostate Cancer with 78 Gy at NTUH
  • 03:18 12.
    Radiotherapy Technology at NTUHfor Prostate Cancer
  • 03:19 13.
    Prostate Cancer Radiotherapy at NTUH
  • 03:22 14.
    Radiotherapy Technology at NTUHfor Prostate Cancer
  • 03:23 15.
    Interim Study of Definitive IMRT for Prostate Cancer with 78 Gy at NTUH
  • 04:25 16.
    Slide 8
  • 05:05 17.
    Overall survival
  • 05:27 18.
    Slide 8
  • 05:30 19.
    Overall survival
  • 06:01 20.
    Prostate cancer specific survival
  • 06:29 21.
    Disease-free survival
  • 07:00 22.
    Biochemical failure
  • 07:41 23.
    Distant Failure
  • 08:07 24.
    Outcome Data
  • 08:27 25.
    攝護腺癌的放射線治療副作用
  • 09:49 26.
    攝護腺癌的放射線治療副作用
  • 11:46 27.
    Toxicity
  • 12:32 28.
    Summary by NTUH Experience 臺大醫院治療成果
  • 13:00 29.
    Survival Comparison between TrialsNo Hormones but 78 Gy or above
  • 13:18 30.
    Survival Comparison between TrialsNo Hormones but 78 Gy or above
  • 13:21 31.
    Survival Comparison between TrialsHormones but RT 70 Gy or less
  • 索引
  • 筆記
  • 全螢幕
【醫藥護人員場】8. Long-term Treatment Outcomes for Localized Prostate Cancer by Risk Group Stratification in Taiwan-放射治療
長度: 14:02, 瀏覽: 1321, 最近修訂: 2017-05-09
演講時間：10:30-11:30
講者：成佳憲教授  
現任職位/稱：
臺大醫院放射腫瘤科主治醫師
臺大醫院腫瘤醫學研究所教授
臺大電機工程研究所博士
臺大醫療機構管理研究所碩士
陽明大學醫學士
 
 
    上一篇 下一篇
    • 00:00 1.
      Long-term Treatment Outcomes for Patients with Localized Prostate Cancer in Taiwan NTUH Experience攝護腺癌的放射治療
    • 00:23 2.
      攝護腺癌的治療種類
    • 00:31 3.
      攝護腺癌的放射線治療病人條件
    • 00:48 4.
      攝護腺癌的放射線治療種類
    • 01:23 5.
      Prostate Cancer Radiotherapy at NTUH
    • 01:34 6.
      Radiotherapy Technology at NTUHfor Prostate Cancer
    • 02:31 7.
      Prostate Cancer Radiotherapy at NTUH
    • 02:36 8.
      Radiotherapy Technology at NTUHfor Prostate Cancer
    • 03:15 9.
      Interim Study of Definitive IMRT for Prostate Cancer with 78 Gy at NTUH
    • 03:16 10.
      Radiotherapy Technology at NTUHfor Prostate Cancer
    • 03:17 11.
      Interim Study of Definitive IMRT for Prostate Cancer with 78 Gy at NTUH
    • 03:18 12.
      Radiotherapy Technology at NTUHfor Prostate Cancer
    • 03:19 13.
      Prostate Cancer Radiotherapy at NTUH
    • 03:22 14.
      Radiotherapy Technology at NTUHfor Prostate Cancer
    • 03:23 15.
      Interim Study of Definitive IMRT for Prostate Cancer with 78 Gy at NTUH
    • 04:25 16.
      Slide 8
    • 05:05 17.
      Overall survival
    • 05:27 18.
      Slide 8
    • 05:30 19.
      Overall survival
    • 06:01 20.
      Prostate cancer specific survival
    • 06:29 21.
      Disease-free survival
    • 07:00 22.
      Biochemical failure
    • 07:41 23.
      Distant Failure
    • 08:07 24.
      Outcome Data
    • 08:27 25.
      攝護腺癌的放射線治療副作用
    • 09:49 26.
      攝護腺癌的放射線治療副作用
    • 11:46 27.
      Toxicity
    • 12:32 28.
      Summary by NTUH Experience 臺大醫院治療成果
    • 13:00 29.
      Survival Comparison between TrialsNo Hormones but 78 Gy or above
    • 13:18 30.
      Survival Comparison between TrialsNo Hormones but 78 Gy or above
    • 13:21 31.
      Survival Comparison between TrialsHormones but RT 70 Gy or less
    位置
    1. 知識庫
    2. ...
    3. 2016臺大攝護祭-醫藥護人員場
    資料夾名稱
    2016臺大攝護祭-醫藥護人員場
    發表人
    系統管理者
    單位
    泌尿部
    建立
    2016-05-10 12:31:00
    最近修訂
    2017-05-09 09:59:23
    長度
    14:02
    1. 知識庫
    2. ...
    3. 2016臺大攝護祭-醫藥護人員場
    1. 1.
      【醫藥護人員場】活動議程
    2. 2.
      【醫藥護人員場】1. Updates of Prostate Cancer Treatment Guidelines 2015/2016: EAU, NCCN, AUA
    3. 3.
      【醫藥護人員場】2. Prostate Cancer Screening、Observation、and Active Surveillance in Taiwan
    4. 4.
      【醫藥護人員場】3. Novel Therapies for Patients with Metastatic Prostate Cancer
    5. 5.
      【醫藥護人員場】4. Radium-223 (Xofigo, 鐳治骨)
    6. 6.
      【醫藥護人員場】5. Enzalutamide (Xtandi, 安可坦)
    7. 7.
      【醫藥護人員場】6. Denosumab (XGEVA, 癌骨瓦)
    8. 8.
      【醫藥護人員場】7. Long-term Treatment Outcomes for Localized Prostate Cancer by Risk Group Stratification in Taiwan-根除手術
    9. 9.
      【醫藥護人員場】8. Long-term Treatment Outcomes for Localized Prostate Cancer by Risk Group Stratification in Taiwan-放射治療
    10. 10.
      【醫藥護人員場】9. Long-term Treatment Outcomes for Localized Prostate Cancer by Risk Group Stratification in Taiwan-冷凍治療
    11. 11.
      【醫藥護人員場】10. Long-term Treatment Outcomes for Localized Prostate Cancer by Risk Group Stratification in Taiwan-HIFU治療
    12. 12.
      【醫藥護人員場】11. Long-term Treatment Outcomes for Localized Prostate Cancer by Risk Group Stratification in Taiwan-綜合比較與總結
    13. 13.
      【醫藥護人員場】12. Novel Life-Prolonging Endocrine Therapies for Metastatic Castration-Resistant Prostate Cancer
    14. 14.
      【醫藥護人員場】13. Medical and Surgical Treatment of Male Urinary Incontinence
    15. 15.
      【醫藥護人員場】14. Prevention and Management of Acute Urinary Retention in Men with Prostate Hypertrophy
    16. 16.
      【醫藥護人員場】15. The Art of Treatment for Nocturia
    17. 17.
      【醫藥護人員場】16. Storage Urinary Symptoms: 2016 Updates
    18. 18.
      【醫藥護人員場】17. Surgical Treatments for Prostate Hypertrophy with Urinary Symptoms 2016
    Copyright © 2017 TMUA, All rights reserved.